Sulkowski MS - Search Results

1

Challenges in treatment of hepatitis C among patients with hepatocellular carcinoma.

Saberi B, Dadabhai AS, Durand CM, Philosophe B, Cameron AM, Sulkowski MS, Gurakar A. Saberi B, et al. Among authors: sulkowski ms. Hepatology. 2017 Aug;66(2):661-663. doi: 10.1002/hep.29126. Epub 2017 Jun 24. Hepatology. 2017. PMID: 28211073 No abstract available.

2

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN. Cummings KJ, et al. Among authors: sulkowski ms. JAMA. 2001 Jan 10;285(2):193-9. doi: 10.1001/jama.285.2.193. JAMA. 2001. PMID: 11176813 Review.

3

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Sulkowski MS, et al. Hepatology. 2002 Jan;35(1):182-9. doi: 10.1053/jhep.2002.30319. Hepatology. 2002. PMID: 11786975

4

Treatment of chronic hepatitis C: a systematic review.

Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA. Chander G, et al. Among authors: sulkowski ms. Hepatology. 2002 Nov;36(5 Suppl 1):S135-44. doi: 10.1053/jhep.2002.37146. Hepatology. 2002. PMID: 12407587 Review.

5

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, El-Kamary SS, Sulkowski M, Bass EB. Gebo KA, et al. Among authors: sulkowski m. Hepatology. 2002 Nov;36(5 Suppl 1):S161-72. doi: 10.1053/jhep.2002.36989. Hepatology. 2002. PMID: 12407590 Review.

6

Hepatitis C in the HIV-infected patient.

Sulkowski MS, Thomas DL. Sulkowski MS, et al. Clin Liver Dis. 2003 Feb;7(1):179-94. doi: 10.1016/s1089-3261(02)00074-0. Clin Liver Dis. 2003. PMID: 12691466 Review.

7

Anemia in the treatment of hepatitis C virus infection.

Sulkowski MS. Sulkowski MS. Clin Infect Dis. 2003;37 Suppl 4:S315-22. doi: 10.1086/376911. Clin Infect Dis. 2003. PMID: 14582000

8

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, Pastore G, Trejo-Estrada R, Horta E Vale A, Wintfeld N, Green J. Hassanein T, et al. J Hepatol. 2004 Apr;40(4):675-81. doi: 10.1016/j.jhep.2003.12.014. J Hepatol. 2004. PMID: 15030985 Clinical Trial.

9

Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person.

Sulkowski MS. Sulkowski MS. Hepatology. 2004 Apr;39(4):906-8. doi: 10.1002/hep.20191. Hepatology. 2004. PMID: 15057892 Review. No abstract available.

10

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. Mehta SH, et al. Among authors: sulkowski ms. Hepatology. 2005 Jan;41(1):123-31. doi: 10.1002/hep.20541. Hepatology. 2005. PMID: 15619237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters